When is cancer surgically removed?

Reasons for surgery.


This is one of the most effective ways to get rid of cancer. After all, it allows you to diagnose cancer, remove it partially or completely, find out its location, eliminate side effects, restore the appearance and much more.
Depending on where the operation will be performed, it depends on several factors, such as the type of operation, the recovery time after it.

Classification of operations by its exclusion.

Diagnosis here we are talking about the fact that the doctor cuts the skin and removes suspicious tissue in the situation.
A biopsy is a biopsy of a cut and excision.
Stage removal of lymph nodes near the tumor.
Removal of tumors (therapeutic surgery).
Tumor removal cuts in the skin, muscles and even bones.
Bunding surgery to remove as many tumors as possible.
Palliative this operation eliminates side effects caused by the tumor.

Moments when you need to relieve pain.

Pain is usually relieved when the tumor causes the following: blockage in different parts of the body, blockage of the intestines, pressure on the spinal cord, bleeding, pressure on the nerve. By the way, bleeding can cause some cancers (e.g. cancer in places with a lot of blood vessels, in sensitive organs).
When it comes to bone fractures, doctors can help the patient by inserting a metal bar to prevent bone fractures.
Thus, cancer requires a rejuvenated appearance, and plastic surgery and self-care can help.



AUTOMATIC GENERIC SUBSTITUTION

Automatic generic substitution (AGS) is the term for a scheme proposed by the Department of Health (DH) in 2009. AGS would have allowed pharmacists to dispense a generic version of a medication (a version with the same active ingredient), even if the doctor had written the prescription for a specific brand.


The Department of Health says no to AGS

After a consultation that resulted in written responses from 423 organisations and individuals, the DH announced, on 14 October 2010, that it had stopped plans to introduce AGS by pharmacists. The DH decided that concerns over patient safety were sufficiently grounded in fact and that it was therefore not appropriate to implement AGS.1

 

Taking Action Works!

The DH decided not to proceed with AGS as it reviewed the responses to the consultation and agreed that AGS was too great a risk to patients.

The correct use of medicines is important for achieving this goal, and the role of pharmacists is fully acknowledged in helping to achieve this. However, it is important that the relevant MHRA legislation is worded accurately to ensure that generic substitution or even therapeutic substitution by pharmacists is not inadvertently embedded in medicines legislation.

Thank you to those that acted last time - we are delighted that the DH listened to us and acted on our concerns.

Hexomedine

Parasinus

Cancer

Losing the right medication for the right patient

Norgine position paper

Norgine discussion. There is no Substitute

Outcome of DoH consultation on generic substitution

14th October 2010

Contacts

Julie Hornby Winfield
Norgine
JWinfield@norgine.com
+44 (0)1895 826642

Jennifer Garratt
Burson-Marsteller
Jennifer.Garratt@bm.com
+44 (0) 207 300 6240

References

  • The proposals to implement 'generic substitution' in primary care, further to the Pharmaceutical Price Regulation Scheme (PPRS) 2009. Response to the consultation.
  • MHRA Consolidation and review of UK medicines legislation. 25 October 2011. http://www.mhra.gov.uk/Publications/Consultations/Medicinesconsultations/MLXs/CON132054 [Last accessed December 2011]

This website is sponsored by Norgine Pharmaceuticals Ltd


MEGS/2739/DEC11

Norgine Automatic Generic Substitution